We presentan algorithmfor monitoringthe concentration of human chonogonadotropin (hCG) in serum at various clinical decision levels with use of fast, simple, and cost-effective qualitative pregnancy test reagents for hCG in serum. Based on correlation between laboratorydata and clinicalobservationsdescribedin the literature,the followingconcentrations of hCG in serum can be considered as clinically significant decision levels: 5 mt. units/L to exclude or "rule out" the presence of increased hCG; 25 mt. units/L for "confirming pregnancy"or confirming the presence of increased hCG from sources other than the trophoblast; and 6500 and 82 500 mt.units/L to enhance the sonographic diagnoses of ectopic pregnancies and molar pregnancies, respectively. We usedTandem Icon II (Hybritech)pregnancytest reagents and evaluated the reagents for possible "false-positive" findings at the 25 mt.units/L limit of hCG detectability by analyzing 100 post-menopausal and more than 4000 premenopausal serum specimens. 
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information for only one predetermined hCG concentration, which is deemed appropriate to demonstrate the existence of pregnancy.
To make maximum use of the new simple, fast, and costeffective "qualitative" pregnancy tests to provide the most relevant information for each of the numerous different clinical uses, one should be able to use the pregnancy test reagents not just to estimate one hCG concentration (i.e., 25 mt.unitWL) to confirm pregnancy, but also to monitor the hCG concentration at any other clinically significant or critical hCG decision levels (26) . This would be especially appropriate if the patient is clinically unstable and (or) a quantitative hCG method is not readily available. For clinically stable patients a quantitative hCG method would probably be the method of choice for some of these applica-
tions.
Here we demonstrate some ways that pregnancy test reagents, with suitably adjusted limits of hCG detectability, could appropriately be used to replace the more timeconsuming and more expensive quantitative hCG methods for use in carefully selected cases.
Materials and Methods

Reagents
We obtained Tandem Icon II (serum) pregnancy 
Setting the Limits for hCG Detection with the Icon II
The manufacturer states in the package insert that the limit of hCG detectability of the Test Zone is 10 mt. unitsfL;
that is, the kit will consistently detect serum hCG concentrations 10 mt. units/L. The standard protocol calls for assay of 0.5 mL of serum. When we assayed 0.5 mL and considered any blue color that appeared in the Test Zone as a positive finding, then the assay's limit of detectability was 10 int. units of hCG (1st IRP) per liter. When we used a 1.0-mL sample and considered any blue color in the Test Zone to be positive, then the limit of detectability was 5 mt.unitsfL. This latter limit was used for the tests intended to "rule out" the possibility of pregnancy.
The limit of detectability of the assay for hCG can be set to 25 int. units/L by comparing the color of the Test Zone with that of the Positive Reference Zone. Therefore, if only those specimens were interpreted as positive for which the color of the Test Zone was equal to or darker than that of the positive Reference Zone, then the limit of detectability was 25 mt.unitsfL. We used this cutoff' value for hCG detectability for the "confirming" pregnancy test and for specimens diluted 260-or 4000-fold with isotonic saline before assay with the Icon H. For the latter two cases the overall cutoff values for positive results were 6500 and 100 000 mt.
units/L (1st IRP), respectively.
Assessing the Precision of Interpreting the Icon II Color
The quality-control To monitor the integrity of the reagents, the lot-to-lot precision of color development, and the precision of interpreting the color of Icon II with a sensitive method, we created an "in-house" serum pool from specimens received in the laboratory for routine pregnancy testing. The hCG in the in-house serum pool was titrated with hCG-free serum from men to yield a test result color that as nearly as possible matched the color of the Positive Reference. Quantitative determinations (MAIA kit; Serono Diagnostics, Inc., Randolph, MA 02368) showed that the hCG concentration of this pooi was 25 mt. units/L, an indication that the sensitivity of the two methods is similar. We stored this serum pool in 1-niL aliquots at -20 #{176}C. Each day of this study and each day during the routine use of Icon II, we analyzed one aliquot from the poo1 to monitor the precision of reagent performance and the technologist-to-technologist interobserver precision of interpretation of the results. The results for the in-house pool were interpreted according to whether the color of the Test Zone was equal to, less than, or more than that of the Positive Reference.
Evaluating for "False-Positive" Results
To evaluate the Icon H for false-positive findings at the 25 int. units/L cutoff value for hCG detectability, we analyzed 100 serum samples from post-menopausal women and more than 4000 samples from pre-menopausal women, using procedures described earlier (4). The 4000 serum samples from women of childbearing years that we tested with the Tandem Icon H had been sent to our laboratories for pregnancy testing. The collection and testing of these spanned more than 25 months and involved many different lots of the reagent kit.
Each specimen was tested at least once, exactly according to the manufacturer's instructions. In addition, the specimens were also tested at cutoff values for hCG detectability other than that recommended by the manufacturer by increasing the sample volume or by diluting the patients' specimens with isotonic saline (see above). All other conditions remained exactly as described by the manufacturer.
To minimize the effect of technologists' subjectivity, two technologists interpreted each potentially ambiguous ELISA test result where the color of the Test Zone was so slight that the first technologist was not certain whether the result was negative or positive. If the second technologist was also uncertain about the result, or found the result to be negative, then the result was reported as negative. In this case, two persons found the result to be not positive. If the second technologist had found the result to be positive, then the result would have been judged as indeterminate, but this did not occur. In our laboratory, similar "indeterminate" results of routine "confirm" pregnancy testing are reported as "negative" with a comment that "a repeat test is suggested after 48 to 72 h."
The hospital medical records of post-menopausal patients whose serum specimens gave positive pregnancy test results at the hCG cutoff values of 10 mt.units/L were examined for relevant information such as clinical diagnosis, presence or absence of malignancies, and drugs.
Validating Reagent Performance at Altered Limits of hCG Detectability
We validated the analytical limits of hCG detectability of the Icon H reagents with serum volumes >0.5 mL as described earlier (4). In brief, we added 2-mL samples of serum containing about 6 mt. units of hCG per liter to the Icon H reagents. The color that developed was indistinguishable from the color of those tests in which 0.5 mL of the 25 mt. units/L samples was used.
Validating the Dilution of Specimens with Isotonic Saline
To validate the use of isotonic saline as diluent for samples containing hCG >25 mt. units/L, we created 20 9-niL hCG-positive serum pools from specimens submitted to our laboratory for routine pregnancy testing. Each of these pools was subdivided into three 3-mL aliquots and stored at -20 #{176}C. The first aliquot of each pool was used for quantitative determination of hCG (by MAIA, calibrated against the 1st LRP). The hCG concentration of these samples varied from 700 to 100 000 mt.units/L. The second aliquot of each pool was diluted with isotonic saline to obtain a final hCG concentration of 25 mt. units/L as follows: we added 25 ML of the aliquot to a volume of the diluent, using 1 mL of diluent for each 1000 mt. units/L increment of hCG determined by the quantitative results for the original hCG concentration. To test the hCG in a serum pool having 6500 mt. unitsfL, we added 25 ML of the serum pool to 6.5 mL of sodium chloride solution. After dilution, each pre-diluted sample was tested by the Icon II reagents exactly according to the manufacturer's instructions.
The third aliquot of the frozen pools was used for repeat tests in case errors were suspected in the results.
Results and Discussion
Several clinical conditions are associated with low hCGectopic pregnancy, undiagnosed abortion, blighted ovum, and "ruling out" early pregnancies for patients who are awaiting surgery, radiotherapy, menstrual regulation, or sterilization-so it is desirable to select the most sensitive pregnancy test for "around-the-clock" routine use.
More-sensitive hCG detection inherently leads to loss of analytical specificity. Thus it is critical that the new, highly In previous communications, we reported our evaluations of the urine and serum Tandem Icon reagents (3, 4), the predecessors of Icon H. Here, we describe some of the characteristics of Tandem Icon H.
Analytical Variables
Precision. The daily use of the "in-house" quality control serum pool shows that the day-to-day and lot-to-lot precision of Icon H color development is remarkably good. Each of the six participating technologists found, day after day and month after month, that the color of the "in-house" control was equal to that of the Positive Reference. The same data also indicate that the run-to-run interobserver agreement was better than 99%. Only on two occasions was the color of the "in-house" control less than that of the Positive Reference. The interpretation of the technologists was again in agreement. The problem was caused by defective reagentsmost likely damaged in shipment, because a new shipment of the same lot of Icon H reagents gave the previous intensity of color for the "in-house" control.
The precision of interpreting the color of unknown samples at 6500 and at 100 000 mt. units of hCG per liter can be expected to be the same or better than that of the "in-housecontrol," because: (a) After appropriate dilutions, the hCG concentration would be the same, in both cases, as that of the "in-house control" (25 mt. units/L). If the hCG concentration of the patients' specimens was >6500 or >100 000 int. units/L, respectively, then the interpretation would be even easier because the color of the diluted unknown would be darker than that of the Positive Reference. (b) A 9 g/L aqueous NaC1 solution was found to be an acceptable diluent (see below). Specificity. The use of specimens from post-menopausal hospitalized women (ages >55 y) for testing for falsepositive results facilitated the screening for interference from a wide variety of diseases, pituitary hormones, and drugs and, at the same time, simplified the interpretation of results. The use of specimens from post-menopausal women allowed us to exclude the possibilities of "subclinical pregnancies"-some of which may not be possible to documentfrom our analysis, because these occur far less frequently in post-menopausal than in pre-menopausal women. We applied such an approach in a previous study (2)to adjust the limit of hCG detectability of a qualitative RIA for urine hCG so as to avoid "false-positive" results. During the following three years, the routine use of the adjusted RIA pregnancy test for testing specimens from women of childbearing years indicated that the experimental design and the selection of urine specimens appeared to be valid for effective screening of pregnancy test methods to avoid "false-positive" results. Table 1 summarizes the results of our evaluation of Icon H for "false-positive" results. We found no specimens from post-menopausal women that had hCG concentrations 25 int. units/L. We found five and seven post-menopausal serum specimens that gave positive results with the Icon H reagents at sensitivities of 10 and 5 mt. units/b hCG, respectively.
Further to increase the specificity of our study, we examined the medical records of patients whose serum samples gave positive results at the 10 mt. units/L limit of hCG detectability, looking for information that would explain the positive results. These patients' illnesses are summarized in Table 1 .
Even though the medical records of these patients did not evidence the presence of either trophoblast or other hCGsecreting tissues, these results cannot be interpreted as "false-positive," because the presence of hCG was confirmed by a quantitative hCG procedure (see Table 1 ). Furthermore, the presence of low hCG concentrations in the blood of post-menopausal women has also been reported by others (6).
A further indication of the high specificity of the Icon H reagents is the following These reagents were used for over 25 
MonitoringhCG Concentrationsat ClinicalDecision Levels
Published laboratory and clinical data (1-26) suggestthat current clinically significant hCG decision levels include the following .5 mt. units/b to "rule out pregnancy" (5) .25 int. units/b to "confirm pregnancy" (1-15) #{149} 6000-6500 mt. units/b, a "discriminatory zone" to enhance the accuracy of diagnosis of ectopic pregnancy by sonography (17-21,26) . .85 000 int. units/b, to enhance the accuracy of diagnosis of molar pregnancy by sonography (25) .
The hCG concentration of 25 000 int. units/L has been implicated to enhance the accuracy of "ruling out" molar pregnancy by sonography, but the existing data are not yet sufficiently firm. Should these findings be validated, testing at a decision level of 25 000 int. units/L hCG can then be added to the algorithm presented in this communication.
The algorithm in Figure 1 depicts the way qualitative serum hCG "pregnancy test" reagents could be used to determine whether the serum hCG is less or greater than the above-listed clinically significant decision levels for hCG. The procedures described in this communication are based on the Icon II reagents, but any other appropriate pregnancy test, if properly validated, could be used to achieve the same objectives. A reagent that could be applied for the described procedures must meet the following three criteria: (a) It must not yield "false-positive" results at the limit of hCG detectability that is used for "confirming pregnancy." A reagent with a lower limit of hCG detectability (higher sensitivity) for "confirming pregnancy" provides a more efficient performance. The following paragraphs are numbered to facilitate reference to the algorithm presented in Figure 1 . The numbers of the paragraphs correspond to the numbers in the algorithm.
1. 'Rule out pregnancy." Low concentrations of hCG (<25 int. units/b) could exist in early or abnormal pregnancies, so the hCG concentration that is generally monitored for confirming pregnancies, even with the more modern pregnancy tests (25 int. units/b), is too high to effectively eliminate the possibility of pregnancy. A higher degree of certainty is desired to "rule out pregnancy" in case the patient is "at risk" of being pregnant (i.e., patients who are awaiting surgery, radiotherapy, roentgenography, menstrual regulation, or sterilization, and when ectopic pregnancy is suspected). A pregnancy test reagent that can test for hCG at the level of 5 mt. units/b could be used to reach this objective.
2. A negative finding for hCG at 5 int. units/b 1st IRP "rules out" pregnancy, or much decreases the possibility of hCG-secreting tissues being present, if a pregnancy is defined as the "existence of an implanted, dividing, fertilized ovum" (5) . serum of nonpregnant humans (6-15) . The clinical significance of the reported "discordant" or "aberrant" results is not yet known, so a positive result at 5 int. unitsfL needs to be followed by a test at the 25 int. units/b limit of hCG detectability.
Normal pregnancy should be considered "confirmed" (if the likelihood of malignancy is small) only if the hCG concentration in the serum exceeds 25 mt. units/L.
"Confirm pregnancy"-"routine pregnancy
testing." As the name implies, the traditional and routine use of pregnancy tests is to "confirm pregnancy" already suggested by clinical history, physical findings, and other information. Currently, many highly specific pregnancy test reagents can be used to confirm pregnancy at 25 int. units/b (1st IRP) (2-
4).
We found several pregnancy test reagents (3,4) that had performance characteristics similar to the Icon H. We selected the Icon H for routine use in our laboratory because:
(a) During our evaluation it did not yield false-positive results at either 25 or at 10 mt. units/b limits of hCG detectability.
(b) The limit of hCG detectability could be lowered to 5 mt. unitsfL by using a larger sample volume. It could be used to "rule out" or "confirm" pregnancy, thus eliminating the need to maintain reagents for an additional assay.
(c) Isotonic saline solution could be used to predilute the unknown specimens when testing for hCG >25 int. units/b.
(d) The color of the reaction was stable, which eliminated the need for exact timing of the last step of the procedure. Other products, similar to the Icon and Icon II reagents, did not have this characteristic (3, 4) . (e) It does not require a gamma counter, and it could be performed without extensive training in the emergency room, at the bedside, or in physicians' offices.
5.
A negative result at 25 int. unitsfL limit of hCG detectability does not "rule out" pregnancy with a high percent of probability, because very early or abnormal pregnancy could exist with hCG values <25 int. unitslL (5) . To "rule out" pregnancy more effectively, repeat the test at 5 int. units/b limit of hCG detectability or repeat the test after 48 to 72 h at 25 int. units/b limit of hCG detectability.
If the results are still negative, the existence of pregnancy can be "ruled out." If the hCG concentration exceeds 5 int. units/b but is less than 25 int. units/b, then early or abnormal pregnancy or other sources of hCG might exist but not be "confirmed."
Concepts outlined in paragraph 3 apply in this case also, and a repeat test is suggested after 48 to 72 h in this case as well. Quantitative determination of hCG might be considered, especially if ectopic pregnancy is suspected.
6. If the hCG concentration exceeds 25 mt. units/L, then pregnancy is confirmed. To verify whether a pregnancy is normal during the first eight weeks, serial determinations of hCG by a quantitative method is recommended, to demonstrate a normal rate of increase in serum hCG concentration (at least 66% increase in 48 to 72 h) (18,20) . 
Even though ectopic pregnancy represents 0.3% to 1% of all pregnancies
and accounts for about 6.5% of maternal death in the United States, definitive diagnosis of ectopic pregnancies is still difficult (16). The usefulness of sonography alone for the diagnosis of ectopic pregnancy is limited, because intra-uterine sac was found on ultrasound examinations in 10% to 20% of patients with ectopic pregnancy (16, 17) . The combined use of intrauterine or adnexal sonography and hCG determinations, however, enhanced the accuracy of the detection of ectopic pregnancies (17-24, 26) . The usefulness of monitoring the "discriminatory zone" of hCG concentration (6000-6500 int. unitsfL) during the first trimester, to detect ectopic pregnancies, has been described (17-21,26) . The hCG concentration was 6000 to 6500 mt.units/b when the sac of a normal intrauterine pregnancy became visible by ultrasound. Only about 10% of ectopic pregnancies had hCG values >6500 int. unita/L when they first presented (17) .
If sonography was positive for intra-uterine
sac and the hCG exceeded 6500 mt. units/b, then the likelihood of ectopic pregnancy was only about 1% to 2%. Such data could be used to lower the concern for ectopic pregnancy before fetal heart activity could be demonstrated. On the other hand, if the fetal sac was not visible by sonography when the hCG was >6500 int. units/b, then the data showed good correlation with ectopic pregnancy. Such a constellation of data could be used to increase the suspicion of ectopic pregnancy (17,24) .
The absence of an intra-uterine sac at hCG below the "discriminatory zone" could not be considered as a diagnostic finding, and could be used neither to increase or decrease the suspicion of ectopic pregnancy.
In contrast, if intrauterine sac was found by sonography at hCG concentrations below the "discriminatory zone," then the data correlated with abnormal pregnancy, either a missed abortion or an ectopic gestation (17, 24). To monitor the "discriminatory zone" by a semiquantitative pregnancy test reagent, a limit of hCG detectability of 6500 or 5000 int. units/b might be appropriate (26) . If the limit of hCG detectability of the pregnancy test reagents is 25 mt. units/b, then the unknown specimens should be diluted 260-fold to change the limit of detectability to 6500 int. units/b. In the case of the Icon H, the hCG concentration in the original unknown is judged to be positive (hCG 6500 int. units/b) if the color density of the Test Zone of the 260-fold diluted specimen is equal to or greater than that of the Positive Reference.
While this communication was being prepared, Gochis et al. (26) also described the use of Icon H for detection of ectopic pregnancies by monitoring the "discriminatory zone" of hCG concentrations in conjunction with sonography. They diluted the patients' specimens 200-fold with hCG-free serum before assay with the Icon II. The dilution converted the cutoff value for hCG detectability of the assay to 5000 int. units of hCG per liter. The clinical false-positive rate for the modified Icon II was 6%. The value of serial quantitative hCG determinations in diagnosing ectopic pregnancies has also been described (20,24).
9.
Because there is an overlap between the hCG titers of normal pregnancies and hydatidiform moles, the determinations of hCG in serum or urine alone for diagnosis of gestational trophoblast are of limited value, especially during the late first and early second trimesters (25) . The diagnosis of hydatidiform moles by ultrasound alone during the first trimester is also difficult, because the vesicles are too small to be resolved by ultrasound.
In contrast, the combined use of hCG determinations and ultrasound have been shown to increase the specificity of diagnosis by sonography.
It has been suggested that hCG titers under 25000 int. unitsfL, when coupled with normal intra-uterine sac, make the diagnosis of hydatidiform mole unlikely (25) .
If values are between 25000 and 85000 int. units of hCG per liter, the presence of an intra-uterine sac in the absence of other sonographic findings may be associated with normal or abnormal pregnancies. In these cases, repeated tests are recommended to make the differential diagnosis. Above 82350 int. unitsfL, the failure to observe a pulsating heart by ultrasound permitted the identification of patients at risk for gestational trophoblastic disease in the first trimester (25) . To monitor hCG >82 350 int. units/b by a semiquantitative pregnancy test reagent, we chose a limit of hCG detectability of 100 000 int. units/b, so as to simplify the scheme of dilutions of the specimen (4000-fold) before assay.
10. If sonography is not available, then serial determination of hCG at about three-day intervals could be used to determine whether the hCG concentration is stable or declining. A titer of hCG that was declining from >100 000 mt. units/b to lower values was consistent with normal pregnancy.
At the University of Texas Medical Branch, after consultations with the staff of the Department of Obstetrics & Gynecology, the clinical chemistry laboratory is providing pregnancy tests at three different sensitivities 24 h a day, seven days a week. All three tests are appearing on the request forms as: "Confirm Pregnancy Test" (25 int. units/b hCG limit of detectability), "Rule Out Pregnancy Test" (5 int. units/L hCG limit of detectability), and "Ectopic Pregnancy Test" (6500 int. units/b hCG limit of detectability).
Conclusions
The Tandem Icon II reagents are applicable to monitoring multiple clinically significant decision levels for hCG in addition to the 25 int. units/b hCG recommended by the manufacturer to "confirm" existence of pregnancy. The enhanced utilization of an appropriate qualitative hCG pregnancy test reagent offers a practical and effective alternative to the use of the far more burdensome and expensive quantitative hCG procedures. These fast and cost-effective qualitative or semiquantitative methods are especially useful in an emergency when the condition of the patient mandates rapid turnaround time and a quantitative hCG method is not applicable or available. If the patient is clinically stable and a quantitative hCG method is available, then a quantitative hCG method could be the method of choice to use with the algorithm described above.
The hCG decision levels of "ruling out" and "confirming" pregnancy are based on clearly formulated clinical needs and analytical principles. The exact limits of hCG detectability used to monitor these decision levels depend mostly on the analytical and clinical specificity of the pregnancy test reagents selected. Currently, state-of-the-art limits of detectability for these hCG decision levels are 5 and 25 mt. unitsIL, respectively. With further experience and improvements in the technology of qualitative hCG determinations, both of these limits of detectability could be revised in the future.
If pregnancy was already suspected from other available information, then it would probably be more efficient to order first a "confirm" pregnancy test and perhaps do the "rule-out" test only if the "confirm" test was negative. However, if pregnancy was not suspected, but ruling out pregnancy would still be desired (i.e., patients awaiting surgery, radiotherapy, roentgenography, menstrual regulation, or sterilization), then ordering the rule-out test first could be more appropriate. In this case, the confirm test would need to be done only if the rule-out test was positive.
The exact limits of hCG detectability to be used for evaluating abnormal pregnancies are somewhat less well defined. Because these clinical hCG decision levels are used in conjunction with sonography, the hCG "discriminatory zones" may vary depending more on the sonographic equipment used, the technique of sonography, the expertise of the sonographer, and the clinical judgement and experience of the attending physician than on the analytical principles of hCG testing. For detection of ectopic pregnancies, Kadar, Romero, and coworkers (17-19,21,24) suggested the use of 6000 to 6500 int. unitsfL hCG (1st IRP) "discriminatory zone," but Nyberg et al. (19,22,23) recommended 1800 mt. units/b (2nd IS) or about 3600 mt. units/L (1st IRP). The algorithm presented in this communication could be adjusted to any other clinical decision levels preferred by individual clinicians. To adjust the algorithm for evaluation of any other clinical hCG decision levels, the limits of hCG detectability of the qualitative hCG pregnancy tests need to be adjusted to the preference of the user. In the case of the Tandem Icon H, the limits of hCG detectability can be adjusted simply by changing the predilution of unknown specimens before the hCG analysis.
The Tandem Icon II (or other similar kit) could perhaps be used without extensive training, but the modified procedures described here should perhaps be performed only by qualified personnel who regularly perform clinical laboratory tests. Well-written protocols could aid the work of less experienced personnel.
